45 related articles for article (PubMed ID: 16178920)
21. Chronic myelogenous leukaemia (CML): an update.
Kumar L
Natl Med J India; 2006; 19(5):255-63. PubMed ID: 17203680
[TBL] [Abstract][Full Text] [Related]
22. Applying the discovery of the Philadelphia chromosome.
Sherbenou DW; Druker BJ
J Clin Invest; 2007 Aug; 117(8):2067-74. PubMed ID: 17671641
[TBL] [Abstract][Full Text] [Related]
23. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Hackanson B; Rückert A; Lübbert M
Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
[No Abstract] [Full Text] [Related]
24. [Chronic myelogenous leukemia].
Urabe A
Nihon Rinsho; 2006 Jul; 64(7):1286-90. PubMed ID: 16838646
[TBL] [Abstract][Full Text] [Related]
25. [Early blastic transformation within a year of imatinib treatment in 2 cases of chronic myeloid leukemia].
Miyazaki K; Kon S; Watanabe T; Togano T; Ohsaka M; Suzuki Y; Danbara M; Horie R; Kanda Y; Maruta A; Higashihara M
Rinsho Ketsueki; 2007 Apr; 48(4):297-304. PubMed ID: 17515120
[TBL] [Abstract][Full Text] [Related]
26. Imatinib resistance in CML.
Volpe G; Panuzzo C; Ulisciani S; Cilloni D
Cancer Lett; 2009 Feb; 274(1):1-9. PubMed ID: 18653275
[TBL] [Abstract][Full Text] [Related]
27. Strategies for the treatment of imatinib-resistant chronic myeloid leukemia.
Hui CH; Hughes TP
Clin Adv Hematol Oncol; 2003 Sep; 1(9):538-45, 559. PubMed ID: 16258446
[TBL] [Abstract][Full Text] [Related]
28. Chronic myeloid leukemia in the imatinib era.
Druker BJ
Semin Hematol; 2003 Apr; 40(2 Suppl 2):1-3. PubMed ID: 12783367
[TBL] [Abstract][Full Text] [Related]
29. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
[TBL] [Abstract][Full Text] [Related]
30. Interferon in chronic myeloid leukaemia: past and future.
Guilhot F; Roy L; Saulnier PJ; Guilhot J
Best Pract Res Clin Haematol; 2009 Sep; 22(3):315-29. PubMed ID: 19959083
[TBL] [Abstract][Full Text] [Related]
31. [Chronic myeloid leukemia].
Hochhaus A
Dtsch Med Wochenschr; 2011 Oct; 136(40):2007-10. PubMed ID: 21960328
[No Abstract] [Full Text] [Related]
32. Imatinib mesylate--a new oral targeted therapy.
Savage DG; Antman KH
N Engl J Med; 2002 Feb; 346(9):683-93. PubMed ID: 11870247
[No Abstract] [Full Text] [Related]
33. [Chronic myeloid leukemia--treatment].
Stoetzer OJ; Hentrich M; Salat C
Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
[No Abstract] [Full Text] [Related]
34. Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
Kata D; Mrówka-Kata K; Seweryn M; Pajak J; Najda J; Kyrcz-Krzemień S
Leuk Res; 2010 Sep; 34(9):e229-31. PubMed ID: 20359744
[No Abstract] [Full Text] [Related]
35. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Ezaki K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
[No Abstract] [Full Text] [Related]
36. Clonal evolution in chronic myelogenous leukemia.
Cortes J; O'Dwyer ME
Hematol Oncol Clin North Am; 2004 Jun; 18(3):671-84, x. PubMed ID: 15271399
[TBL] [Abstract][Full Text] [Related]
37. The biology and treatment of chronic myelogenous leukemia.
Brunstein CG; Mcglave PB
Oncology (Williston Park); 2001 Jan; 15(1):23-31; discussion 31-2, 35. PubMed ID: 11271979
[TBL] [Abstract][Full Text] [Related]
38. Interferon therapy in chronic myelogenous leukemia.
Guilhot F; Roy L; Guilhot J; Millot F
Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
[TBL] [Abstract][Full Text] [Related]
39. Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.
Talpaz M; Hehlmann R; Quintás-Cardama A; Mercer J; Cortes J
Leukemia; 2013 Apr; 27(4):803-12. PubMed ID: 23238589
[TBL] [Abstract][Full Text] [Related]
40. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment.
Preisler HD; Gopal V
Leuk Res; 1994 Mar; 18(3):149-60; discussion 161. PubMed ID: 7511189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
